These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25062856)

  • 21. Gene therapy offers HD patients relief from some symptoms. Tetrabenazine inhibits the transport of a molecule called vesicular monoamine transporter type 2 or VMAT2.
    Morrow T
    Manag Care; 2008 Nov; 17(11):46-7. PubMed ID: 19052001
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuroleptic malignant syndrome induced by combination therapy with tetrabenazine and tiapride in a Japanese patient with Huntington's disease at the terminal stage of recurrent breast cancer.
    Nozaki I; Furukawa Y; Kato-Motozaki Y; Ikeda T; Tagami A; Takahashi K; Ishida C; Komai K
    Intern Med; 2014; 53(11):1201-4. PubMed ID: 24881749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
    Frank S; Ondo W; Fahn S; Hunter C; Oakes D; Plumb S; Marshall F; Shoulson I; Eberly S; Walker F; Factor S; Hunt V; Shinaman A; Jankovic J
    Clin Neuropharmacol; 2008; 31(3):127-33. PubMed ID: 18520979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of tetrabenazine induced depression by selective noradrenaline (norepinephrine) reuptake inhibition.
    Schreiber W; Krieg JC; Eichhorn T
    J Neurol Neurosurg Psychiatry; 1999 Oct; 67(4):550. PubMed ID: 10610387
    [No Abstract]   [Full Text] [Related]  

  • 25. A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea.
    McLellan DL; Chalmers RJ; Johnson RH
    Lancet; 1974 Jan; 1(7848):104-7. PubMed ID: 4130307
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of tetrabenazine on extrapyramidal movement disorders.
    Dalby MA
    Br Med J; 1969 May; 2(5654):422-3. PubMed ID: 4238453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iatrogenic parkinsonism in Huntington's chorea.
    Moss JH; Stewart DE
    Can J Psychiatry; 1986 Dec; 31(9):865-6. PubMed ID: 2948633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetrabenazine Treatment Patterns and Outcomes for Chorea Associated with Huntington Disease: A Retrospective Chart Review.
    Claassen DO; Iyer RG; Shah-Manek B; DiBonaventura M; Abler V; Sung VW
    J Huntingtons Dis; 2018; 7(4):345-353. PubMed ID: 30282372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetrabenazine for the treatment of tardive dyskinesia.
    Leung JG; Breden EL
    Ann Pharmacother; 2011 Apr; 45(4):525-31. PubMed ID: 21487088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetrabenazine as a cause of neuroleptic malignant syndrome.
    Ossemann M; Sindic CJ; Laterre C
    Mov Disord; 1996 Jan; 11(1):95. PubMed ID: 8771075
    [No Abstract]   [Full Text] [Related]  

  • 31. An experimental model for Huntington's chorea?
    Zeef DH; Jahanshahi A; Vlamings R; Casaca-Carreira J; Santegoeds RG; Janssen ML; Oosterloo M; Temel Y
    Behav Brain Res; 2014 Apr; 262():31-4. PubMed ID: 24412685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of tetrabenazine for Huntington's disease-associated chorea.
    Poon LH; Kang GA; Lee AJ
    Ann Pharmacother; 2010 Jun; 44(6):1080-9. PubMed ID: 20442355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetrabenazine for involuntary movement disorders.
    Kingston D
    Med J Aust; 1979 Jun; 1(13):628-30. PubMed ID: 158700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter: Tetrabenazine in chorea.
    Astin KJ; Gumpert EW
    Lancet; 1974 Mar; 1(7856):512. PubMed ID: 4131918
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter: Low-dosage treatment with tetrabenazine.
    Schneider R; Buchan AP; Couston TA
    Br Med J; 1976 May; 1(6019):1212. PubMed ID: 131598
    [No Abstract]   [Full Text] [Related]  

  • 36. Tolerance of tetrabenazine during long-term treatment.
    Mikkelsen BO
    Acta Neurol Scand; 1983 Jul; 68(1):57-60. PubMed ID: 6225292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetrabenazine in the treatment of Huntington's chorea.
    Huang CY; McLeod JG; Holland RT; Elliot C
    Med J Aust; 1976 Apr; 1(16):583-4. PubMed ID: 132600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of tetrabenazine in some hyperkinetic syndromes.
    Pakkenberg H
    Acta Neurol Scand; 1968; 44(3):391-3. PubMed ID: 4235247
    [No Abstract]   [Full Text] [Related]  

  • 39. Combined therapy with tetrabenazine and pimozide in Huntington's chorea: pilot study.
    McArthur AW; Pollock M; Smidt NA
    N Z Med J; 1976 Feb; 83(558):114-6. PubMed ID: 131917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease.
    Kegelmeyer DA; Kloos AD; Fritz NE; Fiumedora MM; White SE; Kostyk SK
    J Neurol Sci; 2014 Dec; 347(1-2):219-23. PubMed ID: 25456459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.